Traws PharmaTRAW
13F holders, Q2 2026 (June 30)33holders +5
12new positions
7sold out
$0.84avg. 13F price*
At the end of Q2 2026, 33 institutions reported holding Traws Pharma Inc. (TRAW) in their 13F filings, up 5 from Q1 2026. 12 opened new positions and 7 sold out. The largest holders were Orbimed Advisors LLC ($1.0M), Ally Bridge Group (NY) LLC ($663K) and Adage Capital Partners Gp, L.L.C. ($616K).
- Company
- Traws Pharma Inc.
- CUSIP
- 68232V884
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $1.4M |
| Exits | 7 | $1.1M |
All 13F filers, Q1 2026 → Q2 2026: 3,729,603 shares bought and 1,193,076 shares sold, net +2,536,527 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| Orbimed Advisors LLC | 0.02% | Add +98.7% | 1,203,260 | $1.0M |
| Ally Bridge Group (NY) LLC | 0.85% | New | 786,236 | $663K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 730,000 | $616K |
| ADAR1 Capital Management, LLC | 0.02% | Add +287.9% | 597,729 | $504K |
| Lynx1 Capital Management LP | 0.05% | Add +3610.5% | 559,470 | $472K |
| Ikarian Capital, LLC | 0.07% | Reduce -29.5% | 478,142 | $403K |
| Sphera Funds Management LTD. | 0.05% | New | 398,486 | $336K |
| Vanguard Capital Management LLC | 0.00% | Add +498.0% | 330,049 | $278K |
| Jane Street Group, LLC | 0.00% | Add +916.9% | 216,006 | $182K |
| Alyeska Investment Group, L.P. | 0.00% | New | 164,376 | $139K |
| Boothbay Fund Management, LLC | 0.00% | Reduce -31.1% | 133,936 | $113K |
| Geode Capital Management, LLC | 0.00% | Add +44.4% | 111,365 | $94K |
| HRT Financial LP | 0.00% | New | 91,220 | $76K |
| Kynam Capital Management, LP | 0.00% | New | 84,400 | $71K |
| Dauntless Investment Group, LLC | 0.12% | Reduce -80.7% | 80,574 | $68K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +71.4% | 54,511 | $46K |
| Northern Trust Corp. | 0.00% | New | 37,454 | $32K |
| State Street Corp. | 0.00% | No change | 25,802 | $22K |
| XTX Topco Ltd | 0.00% | New | 18,092 | $15K |
| SG Americas Securities, LLC | 0.00% | New | 14,524 | $12K |
| Virtu Financial LLC | 0.00% | New | 12,579 | $11K |
| BlackRock, Inc. | 0.00% | Reduce -0.1% | 9,941 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +29.7% | 5,142 | $4K |
| Huntington National Bank | 0.00% | New | 4,676 | $4K |
| UBS Group AG | 0.00% | Reduce -14.8% | 3,451 | $3K |
| Barclays PLC | 0.00% | New | 1,947 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +1244.5% | 1,721 | $1K |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 500 | $414 |
| Morgan Stanley | 0.00% | Reduce -87.5% | 468 | $395 |
| Vanguard Global Advisers, LLC | 0.00% | No change | 262 | $221 |
| Cassaday & Co Wealth Management LLC | 0.00% | Reduce -45.5% | 6 | $6 |
| FMR LLC | 0.00% | Reduce -91.3% | 2 | $2 |
| Jones Financial Companies LLLP | 0.00% | No change | 2 | $2 |
"% of holder's portfolio" is TRAW's weight in each manager's 13F, not the share of Traws Pharma Inc. the manager owns.